Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
3.410
-0.120 (-3.40%)
At close: Oct 5, 2026, 4:00 PM EDT
3.450
+0.040 (1.17%)
After-hours: Oct 5, 2026, 7:56 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $279.76 million as of October 5, 2026. Its market cap has decreased by -21.74% in one year.
Market Cap
279.76M
Enterprise Value
74.87M
1-Year Change
-21.74%
Ranking
Category
Stock Price
$3.41
ChartMarket Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $279.76M, an increase of 3.10%. That is a compound annual growth rate of 1.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 279.76M | -61.40% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 308.97M |
| Abeona Therapeutics | 287.64M |
| Clinuvel Pharmaceuticals | 283.89M |
| Fulcrum Therapeutics | 281.54M |
| Rocket Pharmaceuticals | 281.02M |
| X4 Pharmaceuticals | 280.59M |
| EyePoint | 280.19M |
| Vanda Pharmaceuticals | 279.94M |